Circulation of human papillomavirus (HPV) genotypes in women from córdoba, Argentina, with squamous intraepithelial lesions;Circulación de genotipos de virus papiloma humano (VPH) en mujeres con lesiones intrepiteliales escamosas de córdoba, Argentina

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 54, Issue 1, 2012, Pages 11-16

  Venezuela, Raul Fernando ^a   Kiguen, Ana Ximena ^a   Frutos, Maria Celia ^a   Cuffini, Cecilia Gabriela ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

Argentina; Cervix; Genotypes; HPV; Squamous intraepithelial lesions

Indexed keywords

BETA GLOBIN; VIRUS DNA;

ADULT; AGE; AGED; ARGENTINA; ARTICLE; CONTROLLED STUDY; CYTOLOGY; DNA DETERMINATION; FEMALE; GENE AMPLIFICATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PELVIS; SQUAMOUS INTRAEPITHELIAL LESION; UTERINE CERVIX DISEASE; VIRUS DETECTION; WART VIRUS;

ADOLESCENT; ADULT; AGED; ARGENTINA; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 84857865775     PISSN: 00364665     EISSN: 16789946     Source Type: Journal    
DOI: 10.1590/S0036-46652012000100003     Document Type: Article

References (35)

1. Angulo M, Carvajal-Rodríguez A. Evidence of recombination within human alpha-papillomavirus. Virol J. 2007;4:33
2. Ayres AR, Silva GA. Cervical HPV infection in Brazil: systematic review. Rev Saude Publica. 2010;44:963-74.
3. Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H, et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis. 1994;170:1077-85.
4. Bosch FX, Burchell AN, Schiffman M, Giuliano AR, De Sanjose S, Bruni L, et al. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine. 2008;26(Suppl 10):K1-16.
5. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002; 55:244-65.
6. Camargo M, Soto-De Leon SC, Sanchez R, Perez-Prados A, Patarroyo ME, Patarroyo MA. Frequency of human papillomavirus infection, coinfection, and association with different risk factors in Colombia. Ann Epidemiol. 2011;21:204-13.
7. Chang DY, Chen RJ, Lee SC, Huang SC. Prevalence of single and multiple infection with human papillomaviruses in various grades of cervical neoplasia. J Med Microbiol. 1997;46:54-60.
8. Clifford GM, Rana RK, Franceschi S, Smith JS, Gough G, Pimenta JM. Human papillomavirus genotype distribution in low-grade cervical lesion: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:1157-64.
9. Cobo F, Concha A, Ortiz M. Human papillomavirus (HPV) type distribution in females with abnormal cervical cytology. A correlation with histological study. Open Virol J. 2009;3:60-6.
10. Cuschieri KS, Cubie HA, Whitley MW, Seagar AL, Arends MJ, Moore C, et al. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol. 2004; 57: 68-72.
11. De La Fuente J, Zapardiel I, Benavides P. title typecontributorPatología tumoral benigna del cérvix y lesiones cervicales intraepiteliales/title. In: Bajo Arenas JM, Lailla Vicens JM, Xercavins Montosa J, editores. Fundamentos de Ginecología. Buenos Aires: Editorial Médica Panamericana; 2009. p. 373-380.
12. De Roda Husman AM, Walboomers JM, Van Den Brule AJ, Meijer CJ, Snijders PJ. The use of general primers GP5 and GP6 elongated at their 39 ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol. 1995;76:1057-62.
13. Deluca GD, Lucero RH, Martin De Civetta MT, Vicente L, De Gorodner OL, Schelover E, et al. Human papillomavirus genotypes in women with cervical cytological abnormalities from an area with high incidence of cervical cancer. Rev Inst Med Trop Sao Paulo. 2004;46:9-12.
14. Depuydt CE, Boulet GA, Horvath CA, Benoy IH, Vereecken AJ, Bogers JJ. Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types. J Cell Mol Med. 2007;11:881-91.
15. Gudleviciene Z, Sepetiene A, Didziapetriene J, Valuckas KP, Smailyte G, Drasutiene G, et al. Prevalence of human papillomavirus types in cervical intraepithelial lesions. Medicina (Kaunas). 2010;46:616-23.
16. Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet. 2006;367(9518):1247-55.
17. InfoStat [computer program] versión 2011. Grupo InfoStat, FCA, Universidad Nacional de Córdoba, Argentina. Available from: http://www.infostat.com.ar.
18. International Agency for Research on Cancer (I.A.R.C). Working Group on the evaluation of carcinogenic risks to humans. Human papillomaviruses. Lyon: I.A.R.C; 1995. (I.A.R.C Monographs on the evaluation of carcinogenic risks to humans; v. 64, p. 277-282).
19. Javanbakht M, Gorbach PM, Amani B, Walker S, Cranston RD, Datta SD, et al. Concurrency, sex partner risk, and high-risk human papillomavirus infection among African American, Asian, and Hispanic women. Sex Transm Dis. 2010;37:68-74.
20. Jenkins D. Histopathology and cytopathology of cervical cancer. Dis Markers. 2007;23:199-212.
21. López MJ, Ili GCG, Brebi MP, García MP, Capurro VI, Guzmán GP, et al. Detección y tipificación de virus papiloma humano en lesions preneoplásicas de cuello uterino. Rev Med Chile. 2010; 138:1343-50.
22. Matos E, Loria D, Amestoy GM, Herrera L, Prince MA, Moreno J, et al. Prevalence of human papillomavirus infection among women in Concordia, Argentina: a population-based study. Sex Transm Dis. 2003;30:593-9.
23. Muñoz N, Bosch FX, Shah KV, Meheus A, editors. The epidemiology of cervical cancer and human papillomavirus. Lyon: International Agency for Research on Cancer; 1992. (I.A.R.C. Scientific publication; No. 119).
24. Oliveira-Silva M, Lordello CX, Zardo LM, Bonvicino CR, Moreira MA. Human papillomavirus in Brazilian women with and without cervical lesions. Virol J. 2011;8:4.
25. Pitta DR, Sarian LO, Campos EA, Rabelo-Santos SH, Syrjänen K, Derchain SF. Phylogenetic classification of human papillomavirus genotypes in high-grade cervical intraepithelial neoplasia in women from a densely populated Brazilian urban region. Sao Paulo Med J. 2009;127:122-7.
26. Salih MM, Safi ME, Hart K, Tobi K, Adam I. Genotypes of human papilloma virus in Sudanese women with cervical pathology. Infect Agent Cancer. 2010;5:26.
27. Schiller JT, Castellsagué X, Villa LL, Hildesheim A. An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results. Vaccine. 2008;26(Suppl 10):K53-61.
28. Shimoda K, Lorincz AT, Temple GF, Lancaster WD. Human papillomavirus type 52: a new virus associated with cervical neoplasia. J Gen Virol. 1988;69(Pt 11):2925-8.
29. Sijvarger CC, González JV, Prieto A, Messmer AG, Mallimaci MC, Alonio VL, et al. Epidemiología de la infección cervical por virus papiloma humano en Ushuaia, Argentina. Rev Argent Microbiol. 2006;38:19-24.
30. Smith JF, Brownlow M, Brown M, Kowalski R, Esser MT, Ruiz W, et al. Antibodies from women immunized with Gardasil cross-neutralize HPV 45 pseudovirions. Hum Vaccin. 2007;3:109-15.
31. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287:2114-9.
32. Tate JE, Yang YC, Shen J, Mclachlin CM, Sheets EE, Crum CP. A comparison of early (E7) and late (L1) primer-mediated amplification of papillomaviral DNA in cervical neoplasia. Mol Cell Probes. 1996;10:347-51.
33. Tonon SA, Picconi MA, Zinovich JB, Liotta DJ, Bos PD, Galuppo JA, et al. Human papillomavirus cervical infection and associated risk factors in a region of Argentina with a high incidence of cervical carcinoma. Infect Dis Obstet Gynecol. 1999;7:237-43.
34. Tonon SA, Picconi MA, Zinovich JB, Nardari W, Mampaey M, Galuppo JA, et al. Prevalencia de la infección cervical por virus papiloma humano (HPV) en población caucásica y guarani, residente en la provincia de Misiones, Argentina. Rev Argent Microbiol. 2003;35:205-13.
35. Woodman CB, Collins SI, Young LS. The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer. 2007;7:11-22.